Kaken Pharmaceutical Co (TSE:4521) Other Long-Term Liabilities : 円2,220 Mil (As of Dec. 2023)

View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Other Long-Term Liabilities?

Kaken Pharmaceutical Co's other long-term liabilities for the quarter that ended in Dec. 2023 was 円2,220 Mil.

Kaken Pharmaceutical Co's quarterly other long-term liabilities declined from Jun. 2023 (円2,403 Mil) to Sep. 2023 (円2,329 Mil) and declined from Sep. 2023 (円2,329 Mil) to Dec. 2023 (円2,220 Mil).

Kaken Pharmaceutical Co's annual other long-term liabilities increased from Mar. 2021 (円351 Mil) to Mar. 2022 (円2,664 Mil) but then declined from Mar. 2022 (円2,664 Mil) to Mar. 2023 (円2,189 Mil).

Kaken Pharmaceutical Co Other Long-Term Liabilities Historical Data

The historical data trend for Kaken Pharmaceutical Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Other Long-Term Liabilities Chart

Kaken Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Kaken Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Kaken Pharmaceutical Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Kaken Pharmaceutical Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Kaken Pharmaceutical Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kaken Pharmaceutical Co (TSE:4521) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

KKPCF:USA

Address

28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650

Website

http://www.kaken.co.jp

Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co (TSE:4521) Headlines

No Headlines